{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T09:08:03Z","timestamp":1784797683810,"version":"3.55.0"},"reference-count":4,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Purpose<\/jats:title>\n                  <jats:p>To describe the development of an innovative process to deliver bacillus Calmette-Gu\u00e9rin (BCG) to an offsite urology clinic for bladder instillation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Summary<\/jats:title>\n                  <jats:p>The use of BCG, a live virus vaccine for treatment of patients with localized cancer of the urinary bladder, has created many logistical problems for hospitals and infusion center pharmacies. Due to its short stability, the drug cannot be made ahead of time and coordination with a patient\u2019s arrival at an infusion site is challenging. This becomes exceptionally challenging when a urology clinic has limited compounding capacity and\/or is distant from the site of BCG medication preparation. This article describes an innovative process involving use of closed-system transfer devices (CSTDs) to allow for the administration of BCG in a urology clinic offsite from a medical center\u2019s infusion center facilities.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The use of the CSTD allowed the patients to continue to receive bladder instillations at an offsite urology clinic without significantly disrupting compounding workflow at the small infusion center pharmacy that was the nearest to the clinic.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajhp\/zxaa339","type":"journal-article","created":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T17:36:26Z","timestamp":1603388186000},"page":"60-64","source":"Crossref","is-referenced-by-count":2,"title":["Development of an innovative delivery system for bacillus Calmette-Gu\u00e9rin bladder administration"],"prefix":"10.1093","volume":"78","author":[{"suffix":"Jr","given":"Michael T","family":"Szewczyk","sequence":"first","affiliation":[{"name":"Waterford Care Center, Yale New Haven Health Smilow Cancer Hospital, Waterford, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A","family":"Soefje","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, MN, and Mayo Clinic College of Medicine and Science, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,10,22]]},"reference":[{"key":"2020121603535543000_CIT0001","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1086\/379034","article-title":"Nosocomial Mycobacterium bovis\u2013bacille Calmette-Gu\u00e9rin infections due to contamination of chemotherapeutics: case finding and route of transmission","volume":"188","author":"Vos","year":"2003","journal-title":"J Infect Dis."},{"key":"2020121603535543000_CIT0002","author":"National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention"},{"key":"2020121603535543000_CIT0003","article-title":"General chapter 797.","volume-title":"United States Pharmacopeia and National Formulary (USP 41-NF 36)","author":"United States Pharmacopeial Convention"},{"key":"2020121603535543000_CIT0004","article-title":"General chapter 800.","volume-title":"United States Pharmacopeia and National Formulary (USP 41-NF 36)","author":"United States Pharmacopeial Convention"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/78\/1\/60\/34923637\/zxaa339.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/78\/1\/60\/34923637\/zxaa339.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T09:14:25Z","timestamp":1608110065000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/78\/1\/60\/5935825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,22]]},"references-count":4,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,10,22]]},"published-print":{"date-parts":[[2021,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxaa339","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,1,1]]},"published":{"date-parts":[[2020,10,22]]}}}